Non-canonical CAR-T cell-related toxicities: Emerging strategies and challenges
Journal of Clinical and Experimental Hematology · 2025-11-08 · 4 (1) · 17
DOI: 10.46439/hematol.4.030 ↗At a glance
Journal article in Journal of Clinical and Experimental Hematology, published online on 2025-11-08. Written by Martina Canichella and 1 co-authors. 28 references.
Abstract (original language)
CAR-T cell therapy revolutionized the treatment of patients with relapsed or refractory B-cell hematologic malignancies, substantially altering their prognosis. Alongside its remarkable efficacy, however, this approach is frequently accompanied by treatment-related toxicities. While cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) are the best characterized and usually manageable with standard interventions, a spectrum of additional, non-canonical complications has gained increasing clinical recognition. These include persistent cytopenias (immune effector cell–associated hematologic toxicity, ICAHT), immune effector cell–associated hemophagocytic lymphohistiocytosis–like syndrome (IEC-HS), and coagulopathies. Such events may manifest late, persist for prolonged periods, and significantly compromise patients’ quality of life. In this manuscript, we summarize current evidence and guideline-based recommendations regarding these non-canonical complications, with the aim of providing clinicians a practical framework for their recognition, management, and integration into routine post-infusion care.
Cite
APA
Canichella, M., & Fabritiis, P. D. (2025). Non-canonical CAR-T cell-related toxicities: Emerging strategies and challenges. Journal of Clinical and Experimental Hematology, 4(1), 17. https://doi.org/10.46439/hematol.4.030
Vancouver
Canichella M, Fabritiis PD. Non-canonical CAR-T cell-related toxicities: Emerging strategies and challenges. Journal of Clinical and Experimental Hematology. 2025;4(1):17. doi:10.46439/hematol.4.030
BibTeX
@article{Canichella2025,
author = {Canichella, Martina and Fabritiis, Paolo de},
title = {Non-canonical CAR-T cell-related toxicities: Emerging strategies and challenges},
journal = {Journal of Clinical and Experimental Hematology},
year = {2025},
volume = {4},
number = {1},
pages = {17},
doi = {10.46439/hematol.4.030}
}
EUVIMED